CT perfusion in oncologic imaging: a useful tool?
- PMID: 23255736
- DOI: 10.2214/AJR.11.8476
CT perfusion in oncologic imaging: a useful tool?
Abstract
Objective: This article summarizes the current status of CT perfusion in oncologic imaging, including lesion characterization, staging, prediction of patient outcome or response to therapy, assessment of response to different therapies, and evaluation of tumor relapse. Technical limitations and drawbacks of CT perfusion are also discussed.
Conclusion: Tumor angiogenesis is essential for cancer growth and provides an attractive target for oncologic therapies. CT perfusion is an emerging imaging tool that provides both qualitative and quantitative information regarding tumor angiogenesis.
Similar articles
-
Body perfusion CT: technique, clinical applications, and advances.Radiol Clin North Am. 2009 Jan;47(1):161-78. doi: 10.1016/j.rcl.2008.11.003. Radiol Clin North Am. 2009. PMID: 19195541 Review.
-
Perfusion CT for the assessment of tumour vascularity: which protocol?Br J Radiol. 2003;76 Spec No 1:S36-42. doi: 10.1259/bjr/18486642. Br J Radiol. 2003. PMID: 15456712 Review.
-
Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review.Eur J Radiol. 1999 Jun;30(3):198-205. doi: 10.1016/s0720-048x(99)00012-1. Eur J Radiol. 1999. PMID: 10452718 Review.
-
Perfusion CT: a worthwhile enhancement?Br J Radiol. 2003 Apr;76(904):220-31. doi: 10.1259/bjr/13564625. Br J Radiol. 2003. PMID: 12711641 Review. No abstract available.
-
CT imaging of angiogenesis.Q J Nucl Med. 2003 Sep;47(3):171-87. Q J Nucl Med. 2003. PMID: 12897709 Review.
Cited by
-
Optimal combination of antiangiogenic therapy for hepatocellular carcinoma.World J Hepatol. 2015 Aug 8;7(16):2029-40. doi: 10.4254/wjh.v7.i16.2029. World J Hepatol. 2015. PMID: 26261692 Free PMC article. Review.
-
Assessment of the nature of residual masses at end of treatment in lymphoma patients using volume perfusion computed tomography.Eur Radiol. 2014 Mar;24(3):770-9. doi: 10.1007/s00330-013-3077-6. Epub 2013 Dec 5. Eur Radiol. 2014. PMID: 24306426 Clinical Trial.
-
Multivariable prognostic modelling to improve prediction of colorectal cancer recurrence: the PROSPeCT trial.Eur Radiol. 2024 Nov;34(11):6992-7001. doi: 10.1007/s00330-024-10803-7. Epub 2024 Jun 5. Eur Radiol. 2024. PMID: 38836939 Free PMC article. Clinical Trial.
-
Predicting angiogenesis in adrenal pheochromocytoma: the role of modified parameters from contrast-enhanced CT.Discov Oncol. 2024 Sep 27;15(1):497. doi: 10.1007/s12672-024-01343-z. Discov Oncol. 2024. PMID: 39331234 Free PMC article.
-
Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development.Cancer Metastasis Rev. 2015 Dec;34(4):823-42. doi: 10.1007/s10555-015-9598-5. Cancer Metastasis Rev. 2015. PMID: 26433592 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical